Data from the NERO study investigating Zejula in mesothelioma was presented at the American Association of Cancer Research ...

Boehringer Ingelheim, along with the University of Oxford, UK, and Cumulus Neuroscience, has launched a study for BPD.

The situation began to escalate after Trump’s trade policy announcement on 5 April. The gold standard of business ...

Abeona has won FDA approval for Zevaskyn, setting up a commercial challenge to Krystal Biotech in the rare skin disease ...

MSD has begun construction on a $1bn biologics centre of excellence, Merck Wilmington Biotech, in the US state of Delaware.

When Donald Trump descended a golden escalator at Trump Tower in New York City in 2015 to announce the launch of his first ...

The astronomical rise in popularity of GLP-1RAs in recent years has led to a shortage, prompting users to turn to compounders ...

Biopharmaceutical drug company venture financing witnessed a downturn in Q1 2025 —a 20.2% decline from the $8.1bn raised in ...

The FDA has granted approval for AbbVie’s 15mg Rinvoq (upadacitinib) to treat adults with giant cell arteritis (GCA).

While the pharmaceutical industry is currently exempt from US tariffs, there is an increased risk to the stability of the ...

The FDA approved AstraZeneca's Truqap in November 2023 for the treatment of advanced HR-positive breast cancer.

Caribou is scaling back its operations, halting multiple programmes, and cutting staff to focus on two cancer programmes.